509 related articles for article (PubMed ID: 3006241)
1. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
Derse D; Casey JW
Science; 1986 Mar; 231(4744):1437-40. PubMed ID: 3006241
[TBL] [Abstract][Full Text] [Related]
2. Bovine leukemia virus long terminal repeat: a cell type-specific promoter.
Derse D; Caradonna SJ; Casey JW
Science; 1985 Jan; 227(4684):317-20. PubMed ID: 2981431
[TBL] [Abstract][Full Text] [Related]
3. Activation of enhancer sequences in type II human T-cell leukemia virus and bovine leukemia virus long terminal repeats by virus-associated trans-acting regulatory factors.
Rosen CA; Sodroski JG; Kettman R; Haseltine WA
J Virol; 1986 Mar; 57(3):738-44. PubMed ID: 3005624
[TBL] [Abstract][Full Text] [Related]
4. Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells.
Rosen CA; Sodroski JG; Kettman R; Burny A; Haseltine WA
Science; 1985 Jan; 227(4684):320-2. PubMed ID: 2981432
[TBL] [Abstract][Full Text] [Related]
5. Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency.
Calomme C; Dekoninck A; Nizet S; Adam E; Nguyên TL; Van Den Broeke A; Willems L; Kettmann R; Burny A; Van Lint C
J Virol; 2004 Dec; 78(24):13848-64. PubMed ID: 15564493
[TBL] [Abstract][Full Text] [Related]
6. The bovine leukemia virus X region encodes a trans-activator of its long terminal repeat.
Katoh I; Yoshinaka Y; Sagata N; Ikawa Y
Jpn J Cancer Res; 1987 Feb; 78(2):93-8. PubMed ID: 3030987
[TBL] [Abstract][Full Text] [Related]
7. Bovine leukemia virus: unique structural features of its long terminal repeats and its evolutionary relationship to human T-cell leukemia virus.
Sagata N; Yasunaga T; Ogawa Y; Tsuzuku-Kawamura J; Ikawa Y
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4741-5. PubMed ID: 6087346
[TBL] [Abstract][Full Text] [Related]
8. Characterization of long terminal repeat sequences of HTLV-III.
Starcich B; Ratner L; Josephs SF; Okamoto T; Gallo RC; Wong-Staal F
Science; 1985 Feb; 227(4686):538-40. PubMed ID: 2981438
[TBL] [Abstract][Full Text] [Related]
9. The region between amino acids 245 and 265 of the bovine leukemia virus (BLV) tax protein restricts transactivation not only via the BLV enhancer but also via other retrovirus enhancers.
Tajima S; Aida Y
J Virol; 2000 Dec; 74(23):10939-49. PubMed ID: 11069988
[TBL] [Abstract][Full Text] [Related]
10. A sensitive luminescence syncytium induction assay (LuSIA) based on a reporter plasmid containing a mutation in the glucocorticoid response element in the long terminal repeat U3 region of bovine leukemia virus.
Sato H; Watanuki S; Bai L; Borjigin L; Ishizaki H; Matsumoto Y; Hachiya Y; Sentsui H; Aida Y
Virol J; 2019 May; 16(1):66. PubMed ID: 31109347
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide sequence and structure of integrated bovine leukemia virus long terminal repeats.
Derse D; Diniak AJ; Casey JW; Deininger PL
Virology; 1985 Feb; 141(1):162-6. PubMed ID: 2983496
[TBL] [Abstract][Full Text] [Related]
12. The structure of cloned 3'-terminal RNA region of bovine leukemia virus (BLV).
Tsimanis A; Bichko V; Dreilina D; Meldrais J; Lozha V; Kukaine R; Gren E
Nucleic Acids Res; 1983 Sep; 11(17):6079-87. PubMed ID: 6310526
[TBL] [Abstract][Full Text] [Related]
13. In vivo protein binding and functional analysis of cis-acting elements in the U3 region of the bovine leukemia virus long terminal repeat.
Xiao J; Buehring GC
J Virol; 1998 Jul; 72(7):5994-6003. PubMed ID: 9621062
[TBL] [Abstract][Full Text] [Related]
14. Use of the bovine leukaemia virus LTR U3 promoter for expressing antisense antiviral RNAs and competitive inhibition of viral infection in cell culture.
Shayakhmetov D; Kovalenko D; Yurov G; Borisenko A; Tikchonenko T
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1941-8. PubMed ID: 9266992
[TBL] [Abstract][Full Text] [Related]
15. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
[TBL] [Abstract][Full Text] [Related]
16. Sequence polymorphisms in the long terminal repeat of bovine leukemia virus: evidence for selection pressures in regulatory sequences.
Zhao X; Jimenez C; Sentsui H; Buehring GC
Virus Res; 2007 Mar; 124(1-2):113-24. PubMed ID: 17123656
[TBL] [Abstract][Full Text] [Related]
17. Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements.
Derse D
J Virol; 1987 Aug; 61(8):2462-71. PubMed ID: 3037109
[TBL] [Abstract][Full Text] [Related]
18. An interferon regulatory factor binding site in the U5 region of the bovine leukemia virus long terminal repeat stimulates Tax-independent gene expression.
Kiermer V; Van Lint C; Briclet D; Vanhulle C; Kettmann R; Verdin E; Burny A; Droogmans L
J Virol; 1998 Jul; 72(7):5526-34. PubMed ID: 9621009
[TBL] [Abstract][Full Text] [Related]
19. Bovine leukemia virus trans-activator p38tax activates heterologous promoters with a common sequence known as a cAMP-responsive element or the binding site of a cellular transcription factor ATF.
Katoh I; Yoshinaka Y; Ikawa Y
EMBO J; 1989 Feb; 8(2):497-503. PubMed ID: 2542018
[TBL] [Abstract][Full Text] [Related]
20. Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat.
Rosen CA; Sodroski JG; Haseltine WA
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6502-6. PubMed ID: 2995968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
